Cargando…

O(6)-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma

BACKGROUND: Treatment of glioblastoma (GB), the most common malignant primary brain tumor in adults, can include alkylating chemo-therapeutic agents. Two molecular biomarkers of treatment response are MGMT (O(6)-methylguanine-DNA methyltransferase) promoter methylation and IDH (isocitrate dehydrogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alassiri, Ali H., Alkhaibary, Ali, Al-Sarheed, Saud, Alsufani, Fahd, Alharbi, Mohammed, Alkhani, Ahmed, Aloraidi, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894451/ https://www.ncbi.nlm.nih.gov/pubmed/31804140 http://dx.doi.org/10.5144/0256-4947.2019.410

Ejemplares similares

Primary spinal cord glioblastoma: A rare cause of paraplegia
por: Alharbi, Bashaer, et al.
Publicado: (2022)

Patterns of cervical spine injuries in adults at a major trauma center in Saudi Arabia
por: Alharbi, Ahoud, et al.
Publicado: (2020)

Metastatic brain lesion as the initial presentation of follicular thyroid carcinoma
por: Alanazi, Abdulaziz, et al.
Publicado: (2022)

Prognostic value of O(6)-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas
por: Lam, Keng, et al.
Publicado: (2022)

Erratum to: Prognostic value of O(6)-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas
Publicado: (2022)

Sellar xanthogranuloma: A diagnostic challenge
por: Alharbi, Ahoud, et al.
Publicado: (2022)

The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in glioma
por: Xie, Zhiyan, et al.
Publicado: (2023)

Hypothalamic Lipoma: Outcome of an Intracranial Developmental Lesion
por: Alkhaibary, Ali, et al.
Publicado: (2022)

Prognostic value of isocitrate dehydrogenase 1, O(6)-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients
por: Takahashi, Yoshinobu, et al.
Publicado: (2013)

Oculomotor nerve palsy following coronary artery bypass graft surgery: can pituitary apoplexy complicate the post-operative course of cardiac surgery?
por: Alkhaibary, Ali, et al.
Publicado: (2021)

Traumatic superficial temporal artery pseudoaneurysm: Successful management using endovascular embolization
por: Alkhaibary, Ali, et al.
Publicado: (2021)

Rhino-Orbital-Cerebral Mucormycosis: A Rare Complication of Uncontrolled Diabetes
por: Alanazi, Rahaf F., et al.
Publicado: (2022)

Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma
por: Alzial, Gabriel, et al.
Publicado: (2021)

Regulation of expression of O(6)-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
por: CABRINI, GIULIO, et al.
Publicado: (2015)

Glioblastoma and prolactinoma: a rare simultaneous occurrence
por: Alshalawi, Abdulaziz, et al.
Publicado: (2019)

Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas
por: Hsieh, Kevin Li-Chun, et al.
Publicado: (2017)

The Clinical Significance of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis
por: Zhao, Yu-Hang, et al.
Publicado: (2018)

Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival
por: Robinson, C G, et al.
Publicado: (2010)

Expression of Cathepsins B, D, and G in Isocitrate Dehydrogenase-Wildtype Glioblastoma
por: Koh, Sabrina P., et al.
Publicado: (2017)

Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation
por: Ehret, Felix, et al.
Publicado: (2023)

O(6)-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with MGMT promoter methylation in glioblastoma and anaplastic glioma
por: Bobola, Michael S., et al.
Publicado: (2014)

Changes of O(6)-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse—A Meta-Analysis Type Literature Review
por: Feldheim, Jonas, et al.
Publicado: (2019)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
por: Gittleman, Haley, et al.
Publicado: (2019)

Computer-aided diagnosis of isocitrate dehydrogenase genotypes in glioblastomas from radiomic patterns
por: Lo, Chung-Ming, et al.
Publicado: (2020)

A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma
por: Wang, Lei-Ming, et al.
Publicado: (2021)

Cerebral tuberculoma
por: Khairy, Sami, et al.
Publicado: (2021)

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
por: Polivka, J., et al.
Publicado: (2014)

A Case of Glioblastoma, Isocitrate Dehydrogenase Wild Type, With Widely Disseminated Osseous Metastasis
por: Conte, Brianna, et al.
Publicado: (2022)

Isocitrate dehydrogenase mutations in myeloid malignancies
por: Medeiros, B C, et al.
Publicado: (2017)

Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia
por: Alkhatabi, Heba, et al.
Publicado: (2021)

Chondro-Osseous Metaplasia in Ependymoma: A Rare Histopathological Finding
por: Alkhaibary, Ali, et al.
Publicado: (2020)

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
por: Hasina, Rifat, et al.
Publicado: (2013)

Common Carotid Artery Occlusion in a Young Patient: Can Large-Vessel Stroke Be the Initial Clinical Manifestation of Coronavirus Disease 2019?
por: Alkhaibary, Ali, et al.
Publicado: (2020)

Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults
por: King-Stephens, David
Publicado: (2022)

The T2-FLAIR mismatch sign in glioblastoma, isocitrate dehydrogenase wild-type A case report
por: Nishimura, Shunsuke, et al.
Publicado: (2023)

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
por: Su, Li, et al.
Publicado: (2020)

O6-methylguanine-DNA methyltransferase (MGMT) Promoter methylation is a rare event in soft tissue sarcoma
por: Jakob, Jens, et al.
Publicado: (2012)

The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine
por: Cannella, Lucia, et al.
Publicado: (2023)

Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b2o5ci96emq5pmkcmvamgb0d37